...
机译:戈舍瑞林和来曲唑联合治疗对年轻女性晚期乳腺癌一线内分泌治疗的疗效
Department of Galactophore, the Affiliated Hospital of Medical College, Qingdao University, Qingdao, China;
Department of Galactophore, the Affiliated Hospital of Medical College, Qingdao University, Qingdao, China;
Department of Galactophore, the Affiliated Hospital of Medical College, Qingdao University, Qingdao, China;
Department of Galactophore, the Affiliated Hospital of Medical College, Qingdao University, Qingdao, China;
Department of Galactophore, the Affiliated Hospital of Medical College, Qingdao University, Qingdao, China;
Department of Galactophore, the Affiliated Hospital of Medical College, Qingdao University, Qingdao, China;
Department of Galactophore, the Affiliated Hospital of Medical College, Qingdao University, NO. 59, Haier Road, Qingdao, China;
Advanced breast cancer; Endocrine therapy; Goserelin; Letrozole;
机译:戈舍瑞林和来曲唑联合治疗对年轻女性晚期乳腺癌一线内分泌治疗的疗效
机译:来曲唑与他莫昔芬作为绝经后妇女晚期乳腺癌的一线治疗的III期研究:国际来曲唑乳腺癌小组的生存率分析和疗效更新。
机译:来曲唑相对于他莫昔芬作为绝经后晚期乳腺癌患者的一线治疗的优异疗效:国际来曲唑乳腺癌小组的III期研究结果。
机译:弥漫光学光谱学局部晚期乳腺癌女性新辅助化疗反应的功能成像
机译:在诊断为早期乳腺癌的女性中坚持辅助内分泌治疗。
机译:Bosutinib与芳香酶抑制剂来曲唑的组合:绝经后妇女评估局部晚期或转移性激素受体阳性/ HER2阴性乳腺癌的一线内分泌治疗的II期试验
机译:随机阶段III安慰剂对照试验Letrozole Plus口服Temsirolimus作为患有局部晚期或转移性乳腺癌的绝经后妇女的一线内分泌治疗